Prevention

Home
Prevention

Filter by
Categories
Tags
Authors
Show all

All
Active Clinical Trials
From the Co-Chairs
Institution Spotlights
News in Brief
People
Special Topics
Trial Results

All
Acute myeloid leukemia
Advocacy
Anal cancer
Big data
Bladder cancer
Blood cancer
Breast cancer
Cancer
Cancer care delivery research
Cancer control
Cancer screening
Cancer surveillance
Cardiotoxicity
Chronic lymphocytic leukemia
Chronic myeloid leukemia
Colorectal cancer
Comis symposium
COVID-19
De-escalation
Diversity
Gallbladder cancer
Gender equity
Geriatric oncology
GI cancer
Green tea catechins
Group meeting
Head and neck cancer
Head and neck squamous cell carcinoma
Health equity
Immunotherapy
Leukemia
Lung cancer
Lung inflammation
Lymphoma
Melanoma
Mentorship
Mesothelioma
Multiple myeloma
Myeloma
NCORP
Non-small cell lung cancer
Older adults
Pancreatic cancer
Pancreatic cyst
Pathology
Peripheral neuropathy
Personalized screening
Pneumonitis
Precision medicine
Prevention
Prostate cancer
Proteasome inhibitors
Racism
Radiology
Renal cell
Reproductive health
Sarcoma
Sexuality
Social determinants of health
Survivorship
Symptom control
Targeted therapy
Translational research
Urinary tract cancer
Vaccination

All
Akshay Hanikhindi
Diane Dragaud
ecogacrinnews2
Katie Heller
wpengine

August 17, 2021

August 17, 2021

Now Enrolling: EA8184 for Prostate Cancer

This phase II study is testing the effects and safety of green tea catechins (GTC) as a chemopreventive agent

August 17, 2021

August 17, 2021

EA2185 Pancreatic Cyst Surveillance Study: Amendment #2 Highlights

This study is evaluating two different screening strategies for non-cancerous pancreatic cysts; recently activated amendment #2 expands the eligibility criteria